Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Core decompression with or without stem cells or autogenous bone graft for femoral head osteonecrosis
IRCT20230831059314N1Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mesenchymal stem cells in osteonecrosis of the hip (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Clinical outcomes and Radiologic outcomes. Started Jun 2026; status: recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on IRCT20230831059314N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230831059314N1.